Self-reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe
- PMID: 31571317
- PMCID: PMC7012725
- DOI: 10.1111/ene.14092
Self-reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe
Abstract
Background and purpose: Visual dysfunction is a non-motor symptom of Parkinson disease (PD), but its prevalence is unknown as population-based data on the epidemiology of visual symptoms in PD are lacking. The objective was to determine the prevalence of visual dysfunction in PD.
Methods: This was a cross-sectional analysis of data from adults ≥50 years old in the Survey of Health, Ageing and Retirement in Europe (SHARE), a multinational population-based health survey of adults living in one of 27 European countries and Israel. PD diagnosis was self-reported. Impairment in overall, distance or near eyesight was defined as a score of 4 or 5 on a 1-5 scale. Adjusted logistic regression was used to determine the association between PD and self-reported vision.
Results: There were 115 240 age-eligible participants in the SHARE study (mean age 64.3 years, 54% female), of whom 1438 (1.25%) reported a diagnosis of PD. In adjusted logistic regression models, PD was associated with increased odds of impaired overall [odds ratio (OR) 2.67, 95% confidence interval (CI) 1.91-3.72], distance (OR 2.55, 95% CI 2.04-3.19) and near (OR 2.07, 95% CI 1.69-2.55) eyesight. Individuals with PD were also less likely to report having an eye examination within the previous 2 years (OR 0.59, 95% CI 0.38-0.92), but this did not remain statistically significant after adjusting for confounders (OR 0.76, 95% CI 0.47-1.24).
Conclusions: Visual dysfunction is significantly more common in PD than in the general adult population. Visual symptoms are a potentially under-recognized and under-treated source of reduced quality of life in PD patients that require further attention and study.
Keywords: Parkinson disease; epidemiology; non-motor symptoms; vision; visual dysfunction.
© 2019 European Academy of Neurology.
References
-
- Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015. October;30(12):1591–601. - PubMed
-
- Ekker MS, Janssen S, Seppi K, Poewe W, de Vries NM, Theelen T, et al. Ocular and visual disorders in Parkinson’s disease: Common but frequently overlooked. Parkinsonism Relat Disord. 2017. July;40:1–10. - PubMed
-
- Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson’s disease. Neurology. 2004. January 27;62(2):177–80. - PubMed
Publication types
MeSH terms
Grants and funding
- P01 AG005842/AG/NIA NIH HHS/United States
- RC2 AG036619/AG/NIA NIH HHS/United States
- T32 NS061779/NS/NINDS NIH HHS/United States
- R01 NS099129/NS/NINDS NIH HHS/United States
- R01 AG030153/AG/NIA NIH HHS/United States
- CIT4-CT-2006-028812/European Commission/International
- P30 AG012815/AG/NIA NIH HHS/United States
- HHSN271201300071C/AG/NIA NIH HHS/United States
- U01 AG009740/AG/NIA NIH HHS/United States
- Max Planck Society for the Advancement of Science/International
- Y1-AG-4553-01/US National Institute on Aging/International
- OGHA_04-064/US National Institute on Aging/International
- R03 AG043052/AG/NIA NIH HHS/United States
- N°211909/European Commission/International
- R21 AG025169/AG/NIA NIH HHS/United States
- N°261982/European Commission/International
- CIT5-CT-2005-028857/European Commission/International
- German Ministry of Education and Research/International
- N°227822/European Commission/International
- P01 AG008291/AG/NIA NIH HHS/United States
- QLK6-CT-2001-00360/European Commission/International
- IAG_BSR06-11/US National Institute on Aging/International
- RII-CT-2006-062193/European Commission/International
LinkOut - more resources
Full Text Sources
Medical
